Will Illumina (ILMN Stock) see further gains this year? [Video]
![Will Illumina (ILMN Stock) see further gains this year? [Video]](https://editorial.fxstreet.com/images/Markets/Equities/iStock_000017292947_Large_XtraLarge.jpg)
Illumina is an American company which develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. It has also got recent backing to track new emergence of new COVID-19 strains. Seasonally this is a strong time of year for Illumina. From January 11 to January 25 the shares have gained in 10 out of the last 15 years. There has been an average gain of +6.86% and the largest loss was -8.92% in 2008.
Trade Risks: The main risk to this trade is if further risk off tones develop and drag US stocks lower.
Premium
You have reached your limit of 3 free articles for this month.
Start your subscription and get access to all our original articles.
Author

Giles Coghlan LLB, Lth, MA
Financial Source
Giles is the chief market analyst for Financial Source. His goal is to help you find simple, high-conviction fundamental trade opportunities. He has regular media presentations being featured in National and International Press.


















